Literature DB >> 25667272

There are two prophylactic human papillomavirus vaccines against cancer, and they are different.

Wiebren A A Tjalma1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25667272     DOI： 10.1200/JCO.2014.59.0331

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination.

Authors:  Sonja Fischer; Marcus Bettstetter; Andrea Becher; Marlene Lessel; Cyril Bank; Matthias Krams; Ingrid Becker; Arndt Hartmann; Wolfgang Jagla; Andreas Gaumann
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

2.  A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium.

Authors:  W A A Tjalma; X B Trinh; M Rosenlund; A P Makar; F Kridelka; D Rosillon; P A Van Dam; S Collas De Souza; K Holl; P Simon; D Jenkins
Journal:  Facts Views Vis Obgyn       Date:  2015

Review 3.  Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer.

Authors:  Xaveer Van Ostade; Martin Dom; Wiebren Tjalma; Geert Van Raemdonck
Journal:  Arch Gynecol Obstet       Date:  2017-11-15       Impact factor: 2.344

Review 4.  Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer.

Authors:  Aranzazu Jauregui-Amezaga; Séverine Vermeire; Hans Prenen
Journal:  Ann Gastroenterol       Date:  2016 Apr-Jun

Review 5.  Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus.

Authors:  Maryam Dadar; Sandip Chakraborty; Kuldeep Dhama; Minakshi Prasad; Rekha Khandia; Sameer Hassan; Ashok Munjal; Ruchi Tiwari; Kumaragurubaran Karthik; Deepak Kumar; Hafiz M N Iqbal; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-11-12       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.